Browse by Medical Category
The Andrew L. Warshaw, MD, Institute for Pancreatic Cancer Research
Thursday, July 15, 2010
UKâ€“US collaboration building up a database for personalized cancer treatment
The largest study to correlate genetics with response to
cancer drugs releases its first results today. The researchers behind the
study, based at Massachusetts
General Hospital Cancer Center
and the Wellcome Trust Sanger Institute, describe in this initial dataset the
responses of 350 cancer samples to 18 anticancer therapeutics.
These first results, made freely available on the Genomics
of Drug Sensitivity website, will help cancer researchers around the world to
seek better understanding of cancer genetics and could help to improve
Link to full Wellcome Trust Sanger Institute news release.
Katie Marquedant, 617 726-0337, firstname.lastname@example.org
Back to Top